161 related articles for article (PubMed ID: 2076403)
1. Use of nifedipine in hypertension and Raynaud's phenomenon.
Kiowski W; Erne P; Bühler FR
Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():935-40. PubMed ID: 2076403
[TBL] [Abstract][Full Text] [Related]
2. Nifedipine in pulmonary arterial hypertension. Importance of Raynaud's phenomenon.
Fisher J; Mack RJ; Likier HM; Schiff AN; Borer JS
Chest; 1987 Sep; 92(3):400-5. PubMed ID: 3622018
[TBL] [Abstract][Full Text] [Related]
3. Place of calcium antagonists in the treatment of hypertension.
Kiowski W
Cor Vasa; 1990; 32(2 Suppl 1):2-11. PubMed ID: 2200638
[TBL] [Abstract][Full Text] [Related]
4. Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation.
Malamet R; Wise RA; Ettinger WH; Wigley FM
Am J Med; 1985 Apr; 78(4):602-8. PubMed ID: 3157318
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Raynaud's phenomenon with calcium channel blockers.
Smith CR; Rodeheffer RJ
Am J Med; 1985 Feb; 78(2B):39-42. PubMed ID: 3976694
[TBL] [Abstract][Full Text] [Related]
6. Raynaud's phenomenon: pathophysiologic features and treatment with calcium-channel blockers.
Smith CR; Rodeheffer RJ
Am J Cardiol; 1985 Jan; 55(3):154B-157B. PubMed ID: 3881908
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of Raynaud's phenomenon.
Belch JJ; Ho M
Drugs; 1996 Nov; 52(5):682-95. PubMed ID: 9118818
[TBL] [Abstract][Full Text] [Related]
8. Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.
Anderson JE; Held N; Wright K
Pediatrics; 2004 Apr; 113(4):e360-4. PubMed ID: 15060268
[TBL] [Abstract][Full Text] [Related]
9. Nifedipine in primary Raynaud's phenomenon and in scleroderma: oral versus sublingual hemodynamic effects.
Wollersheim H; Thien T; van 't Laar A
J Clin Pharmacol; 1987 Nov; 27(11):907-13. PubMed ID: 3429697
[TBL] [Abstract][Full Text] [Related]
10. [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
Vayssairat M; Blaison N; Baudot N; Evenou P; Gilard M; Mathieu JF
J Mal Vasc; 1989; 14(4):299-302. PubMed ID: 2584886
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
Coleiro B; Marshall SE; Denton CP; Howell K; Blann A; Welsh KI; Black CM
Rheumatology (Oxford); 2001 Sep; 40(9):1038-43. PubMed ID: 11561116
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
[TBL] [Abstract][Full Text] [Related]
13. Effects of nifedipine therapy on pulmonary Raynaud's in primary Sjögren's syndrome.
Joseph BZ; Organek HW; Grant A; Axelrod DA
Clin Exp Rheumatol; 1988; 6(4):409-10. PubMed ID: 3229032
[TBL] [Abstract][Full Text] [Related]
14. Digital and radial artery blood flow in patients with Raynaud's phenomenon in response to nifedipine.
Morgan RH; Psaila JV; Davies WT; Carolan G; Woodcock JP
Eur J Vasc Surg; 1987 Dec; 1(6):403-8. PubMed ID: 3503035
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of sublingual nifedipine in patients with Raynaud's phenomenon.
Gush RJ; Taylor LJ; Jayson MI
J Cardiovasc Pharmacol; 1987 May; 9(5):628-31. PubMed ID: 2439846
[TBL] [Abstract][Full Text] [Related]
16. Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis.
Meyrick Thomas RH; Rademaker M; Grimes SM; MacKay A; Kovacs IB; Cook ED; Bowcock SM; Kirby JD
Br J Dermatol; 1987 Aug; 117(2):237-41. PubMed ID: 3307894
[TBL] [Abstract][Full Text] [Related]
17. Nifedipine and alpha 1-adrenergic blockade in Raynaud's phenomenon.
Kahan A; Foult JM; Weber S; Amor B; Menkes CJ; Degeorges M
Eur Heart J; 1985 Aug; 6(8):702-5. PubMed ID: 4054140
[TBL] [Abstract][Full Text] [Related]
18. Nifedipine-induced fingertip vasodilation in patients with Raynaud's phenomenon.
Creager MA; Pariser KM; Winston EM; Rasmussen HM; Miller KB; Coffman JD
Am Heart J; 1984 Aug; 108(2):370-3. PubMed ID: 6380254
[TBL] [Abstract][Full Text] [Related]
19. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.
Smith CD; McKendry RJ
Lancet; 1982 Dec; 2(8311):1299-301. PubMed ID: 6128596
[TBL] [Abstract][Full Text] [Related]
20. Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls.
Leppert J; Nilsson H; Myrdal U; Edvinsson L; Hedner T; Ringqvist I
Cardiovasc Drugs Ther; 1993 Dec; 7(6):901-7. PubMed ID: 8011569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
